Literature DB >> 23406213

Multiple myeloma lesion detection with whole body CT versus radiographic skeletal survey.

Kelechi Princewill1, Sampson Kyere, Omer Awan, Michael Mulligan.   

Abstract

OBJECTIVE: To compare accuracy of CT versus radiographs in detecting myeloma lesions.
MATERIALS AND METHODS: Retrospective review of patients who were simultaneously evaluated with radiographs and PET/CT scans. Two radiologists independently assessed each modality.
RESULTS: Total number of lesions detected with CT was 968 versus 248 for radiographs (p < .001). Nine patients (18%) had no lesions on either CT or radiographs. Of the remaining 42 patients, 39 had more lesions on CT. CT could have resulted in upstaging of disease in 31 cases (61%).
CONCLUSION: CT is superior for detecting myeloma lesions.

Entities:  

Mesh:

Year:  2013        PMID: 23406213     DOI: 10.3109/07357907.2013.764565

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  20 in total

1.  Improvement of diagnostic confidence for detection of multiple myeloma involvement of the ribs by a new CT software generating rib unfolded images: Comparison with 5- and 1-mm axial images.

Authors:  Georg Homann; Katja Weisel; Deedar Farhad Mustafa; Hendrik Ditt; Konstantin Nikolaou; Marius Horger
Journal:  Skeletal Radiol       Date:  2015-04-02       Impact factor: 2.199

2.  Value of low-dose whole-body CT in the management of patients with multiple myeloma and precursor states.

Authors:  F Joseph Simeone; Joel P Harvey; Andrew J Yee; Elizabeth K O'Donnell; Noopur S Raje; Martin Torriani; Miriam A Bredella
Journal:  Skeletal Radiol       Date:  2018-09-14       Impact factor: 2.199

3.  Vertebral lesion distribution in multiple myeloma--assessed by reduced-dose whole-body MDCT.

Authors:  Georg Bier; Christopher Kloth; Christoph Schabel; Malte Bongers; Konstantin Nikolaou; Marius Horger
Journal:  Skeletal Radiol       Date:  2016-01       Impact factor: 2.199

4.  Baseline bone involvement in multiple myeloma - a prospective comparison of conventional X-ray, low-dose computed tomography, and 18flourodeoxyglucose positron emission tomography in previously untreated patients.

Authors:  Maja Hinge; Kristian T Andersen; Thomas Lund; Henrik B Jørgensen; Paw C Holdgaard; Tina E Ormstrup; Lone L Østergaard; Torben Plesner
Journal:  Haematologica       Date:  2016-07-06       Impact factor: 9.941

5.  Improved MDCT monitoring of pelvic myeloma bone disease through the use of a novel longitudinal bone subtraction post-processing algorithm.

Authors:  Marius Horger; Wolfgang M Thaiss; Hendrik Ditt; Katja Weisel; Jan Fritz; Konstantin Nikolaou; Shu Liao; Christopher Kloth
Journal:  Eur Radiol       Date:  2016-11-23       Impact factor: 5.315

6.  Whole-body ultra-low dose CT using spectral shaping for detection of osteolytic lesion in multiple myeloma.

Authors:  Saravanabavaan Suntharalingam; Christian Mikat; Axel Wetter; Nika Guberina; Ahmed Salem; Philipp Heil; Michael Forsting; Kai Nassenstein
Journal:  Eur Radiol       Date:  2018-01-10       Impact factor: 5.315

7.  Whole-body low-dose computed tomography in multiple myeloma staging: Superior diagnostic performance in the detection of bone lesions, vertebral compression fractures, rib fractures and extraskeletal findings compared to radiography with similar radiation exposure.

Authors:  Lukas Lambert; Petr Ourednicek; Zuzana Meckova; Giampaolo Gavelli; Jan Straub; Ivan Spicka
Journal:  Oncol Lett       Date:  2017-02-13       Impact factor: 2.967

Review 8.  Oncologist perspective: role of imaging in myeloma.

Authors:  Yael N Shapiro; Elizabeth K O'Donnell
Journal:  Skeletal Radiol       Date:  2021-07-17       Impact factor: 2.199

Review 9.  New Approaches to Molecular Imaging of Multiple Myeloma.

Authors:  Ravi Vij; Kathryn J Fowler; Monica Shokeen
Journal:  J Nucl Med       Date:  2015-11-05       Impact factor: 10.057

10.  Whole Body Low Dose Computed Tomography (WBLDCT) Can Be Comparable to Whole-Body Magnetic Resonance Imaging (WBMRI) in the Assessment of Multiple Myeloma.

Authors:  Davide Ippolito; Teresa Giandola; Cesare Maino; Davide Gandola; Maria Ragusi; Pietro Andrea Bonaffini; Sandro Sironi
Journal:  Diagnostics (Basel)       Date:  2021-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.